Overview

The International Finance Facility for Immunisation was set up in 2006 to rapidly accelerate the availability and predictability of funds for Gavi's immunisation programmes

IFFIm's funding mechanism

Vaccine bonds

The International Finance Facility for Immunisation (IFFIm) uses long-term pledges from donor governments to sell 'vaccine bonds' in the capital markets, making large volumes of funds immediately available for Gavi programmes.

Launched in 2006, IFFIm was the first aid-financing entity in history to attract legally-binding commitments of up to 20 years from donors and offers the "predictability" that developing countries need to make long-term budget and planning decisions about immunisation programmes.

Augmenting existing support

IFFIm not only provides a market-based return, it saves lives. This is proven.  

René Karsenti, IFFIm Board Chair

IFFIm has transformed Gavi’s financial landscape, nearly doubling Gavi’s funding for immunisation programmes in the initial years of IFFIm’s operations.

IFFIm benefits from US$ 6.5 billion in donor contributions over 25 years from the governments of Australia, France, Italy, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom.

These long-term pledges support the issuance of vaccine bonds and sukuks, which have been issued in various markets and various currencies, and proved remarkably popular with institutional and individual investors who want a market-based return and an ethical investment opportunity.

With the World Bank as its treasury manager, IFFIm has leveraged donor pledges to raise more than US$ 5.7 billion over the 2006 to 2016 period.

40 million

In September 2014, Nepal became the first country to introduce inactivated polio vaccine (IPV) with Gavi support. By the end of 2016, 54 countries had introduced the vaccine with our support, collectively immunising more than 40 million children.

Gavi

More facts...

close icon

modal window here